Centre for Research and Applications in Fluidic Technologies

A team of researchers has developed a new approach to analyzing DNA evidence in sexual assault cases – one that could reduce lengthy delays in the processing of evidence.

While there are almost half a million sexual assaults in Canada every year, many more go unreported because victims are reluctant to come forward.

One of the reasons cited by victims is that analysis of forensic evidence is too slow.

Mohamed Elsayed (supplied image)

“For this research, we read reports and surveys that asked victims why they weren’t reporting assaults,” says the study’s lead author Mohamed Elsayed, who worked on the project as part of his PhD in biomedical engineering at the �ؿ�ζSM. “And the most common answer was that they didn't have confidence in the justice system – and that lack of confidence was partly because of how long the process takes.”

Elsayed, now a post-doctoral researcher in the department of chemistry in the Faculty of Arts & Science, co-authored the study with, among others, Leticia Bodo, a master’s student in the department of chemistry, and Aaron Wheeler, a professor in the department of chemistry, the Institute of Biomedical Engineering and the Centre for Research and Applications in Fluidic Technologies, a U of T institutional strategic initiative.

All three researchers are also affiliated with the Donnelly Centre for Cellular and Biomolecular Research.

Processing forensic evidence in sexual assault cases is a technical, multi-step process that involves collecting DNA evidence and sending it to a well-equipped forensic laboratory for analysis by a skilled technician. Once there, the sample is first processed to isolate the assailant’s DNA from the victim’s so the assailant’s DNA can then be analyzed and used to identify a suspect.

The entire process can take days, weeks or longer. Most of that time is taken up with transporting the evidence to the lab, where its analysis can be further delayed depending on how many other cases are being investigated.

To speed things up, researchers focused on the first step: separating two individuals’ DNA from a single sample. At present, this is usually done manually by trained and experienced experts.

Elsayed and his collaborators, by contrast, developed a process called ’differential digestion” using digital microfluidics that helped simplify the overall process and reduce the number of manual steps needed to isolate the assailant’s DNA from 13 to five. “Also, because micro-fluidic processes tend to be faster, we expect that one of the eventual benefits will be shortening the overall time needed,” says Elsayed.

What’s more, the new approach could lead to a mobile solution that no longer requires a lab. For example, testing could be done at a hospital, circumventing the lab’s queue.

The new technique, described in a paper published in the journal Advanced Science, is compatible with the technology known as Rapid DNA analysis that is already in use for the second step of identifying an individual from their DNA. The study’s authors, which included researchers from U of T Mississauga’s forensic science program, say the long-term goal is to integrate the two technologies to make the process even more streamlined.

While there remain several challenges to deploying the new technique, Elsayed says he is confident they can be overcome and has turned his efforts toward making it widely accessible and commercially viable.

“Our plan is to develop an instrument that will do in five minutes what currently takes 45,” says Elsayed. “And to run many more samples than previously. Once we do that, the next step would be to introduce the technology to forensic labs and hospitals.

“It will take years, but the potential is very exciting.”

The research was supported by the ANDE Corporation and NSERC Alliance Society.

"I’m grateful to NSERC for having the foresight to establish the ‘Alliance Society’ program which has a mission to ‘address a societal challenge that will result in new natural sciences and engineering knowledge and societal impact,” Wheeler says.

Add new story tags

Forensic Science

Academic hospital network joins centre for research on microfluidic devices for human health

Christopher.Sorensen — Wed, 14 Feb 2024 17:05:46 +0000

Academic hospital network joins centre for research on microfluidic devices for human health

Christopher.Sorensen Wed, 02/14/2024 - 12:05

Cutline

Researchers work in the Device Foundry, one of three facilities that are part of the Centre for Research and Applications in Fluidic Technologies (photo by Dahlia Katz)

Tyler Irving

Topic

Our Community

Institutional Strategic Initiatives

Temerty Faculty of Medicine

Unity Health

Faculty of Applied Science & Engineering

Research & Innovation

Subheadline

The Centre for Research and Applications in Fluidic Technologies, or CRAFT, is a partnership between U of T, the National Research Council of Canada and, now, Unity Health Toronto

The Centre for Research and Applications in Fluidic Technologies (CRAFT) has expanded to formally include Unity Health Toronto, an academic hospital network and leading Canadian health research institute.

A partnership between the �ؿ�ζSM, the National Research Council of Canada (NRC) and now Unity Health Toronto, CRAFT develops leading-edge microfluidic devices – technologies that take advantage of the fundamental difference in behaviour of many fluids at the micro-scale – that can address many challenges in human health.

The latest agreement, which includes $21 million in new investments and an extension of the partnership to 2028, will support dozens of U of T trainees who will work alongside NRC scientists and engineers, as well as clinical scientists, on projects related to diagnostics bio-fabrication and organ-on-chip systems.

With the addition of Unity Health Toronto, clinicians will now join CRAFT scientists in developing new microfluidic technologies such as detection and monitoring risks of infection in intensive care unit (ICU) environments and rapid detection of arterial peripheral diseases. This will allow scientists and clinicians to directly test and validate their technologies in care settings, and develop new pathways to work with industry partners.

“CRAFT was built from the common vision that microfluidics could make a real impact on Canada’s scientific and clinical fields,” says Teodor Veres, director of R&D at the NRC’s Medical Devices Research Centre and co-director of CRAFT.

“Focused on providing new student generations with opportunities to forge ground-breaking scientific and technological advancements in microfluidic devices, these advancements have the potential to revolutionize disease diagnosis and treatment in Canada and globally. This vision was crucial to our initiative’s growth and our current success.”

Left to right: Claudia dos Santos, Pamela Plant, Valeria DiGiovanni and Marlene Santos at the CRAFT Translational Research Station inside the Medical Surgical ICU at St. Michael’s Hospital (photo by Unity Health Toronto)

Microfluidics refers to the study of fluids’ unique behaviours at the scale of microns – one thousandth of a millimetre – or smaller, as well as the design and manufacture of devices with tiny channels or other features that can precisely control these fluids. That, in turn, offers new approaches to a variety of challenges in engineering, medicine, biology and chemistry by miniaturizing, automating or innovating on established laboratory techniques.

Applications include rapid diagnostic devices that help clinicians to reliably test for the presence of certain diseases at the patient’s bedside while avoiding the cost and time delays associated with sending samples to large testing laboratories. Microfluidics are also used in biosensors that allow patients in remote communities to send accurate data to specialists located hundreds of kilometres away.

As an example, Claudia dos Santos, Unity Health critical care physician and scientist, has pinpointed a need to quickly identify ICU patients at risk of sepsis. She is working with CRAFT researchers to develop a microfluidic instrument that can detect biomarkers for sepsis on the ICU floor. Such an instrument will allow for faster diagnosis and treatment of sepsis, which can be deadly if left untreated.

“With Unity Health Toronto formally joining CRAFT, we are bringing the power and potential of microfluidic devices into clinical settings. This partnership will allow clinicians to merge their expertise with CRAFT scientists, and take the next major steps towards transforming patient care,” says dos Santos, who is an associate professor in the department of laboratory medicine and pathobiology in the Temerty Faculty of Medicine.

Another application of microfluidics, known as organ-on-a-chip, enables cells, tissues or even portions of working organs to be grown outside the body in microfluidic devices. These biological models can be used in high-throughput screening of large libraries of potentially therapeutic molecules for specific functions – for example, determining which ones would be most effective against a particular type of cancer. Such screens could even suggest the ideal therapies for an individual patient, opening the door to precision medicine.

CRAFT was founded in 2018 and includes three research and development facilities for microfluidic devices: the Tissue Foundry for bioprinting and device preclinical validation; the Device Foundry for microfluidic device design, prototyping and small-scale fabrication; and the NRC Device Fabrication and Scale-Up facility. The first two are located at U of T and available for use by academics, students, industry and government. The latter is located on the NRC campus in Boucherville, Que.

In 2023, the facilities hosted 125 unique users from across U of T as well as partner hospitals, including Sunnybrook, the Hospital for Sick Children and University Health Network. Since its inception, CRAFT has engaged 44 researchers and 114 trainees in a wide range of projects, leading to 69 peer-reviewed publications, 22 patent submissions and three spin-off companies.

“CRAFT has been a team effort all along. In addition to the NRC, we have been supported as an institutional strategic initiative through U of T’s Division of the Vice-President, Research and Innovation, and by U of T’s faculties of Engineering, Arts & Science, Medicine and Pharmacy. We all look forward to an exciting next chapter in partnering with Unity Health,” says Axel Guenther, a professor of mechanical engineering at U of T and co-director of CRAFT.

“Developing the next generation of made-in-Canada microfluidic technologies and bringing them to the people who need them most – patients, health-care professionals and pharmaceutical companies – will require strong partnerships within and outside of CRAFT, with our clinical partners, U of T’s entrepreneurship ecosystem and Canadian industry.

“We invite everyone to visit and use our open research facilities in Toronto, attend our Microfluidics Professional Course on July 17-19, or attend our research symposium in Boucherville on Oct. 12, 2024.”

Add new story tags

Centre for Research and Applications in Fluidic Technologies